Answers are grounded in this paper and cite their sources.
RGTAs are effective biological agents for the treatment of corneal epithelial defects following severe ocular surface chemical injuries.
No takes yet. Share an insight, caveat, or question.
Ustaoğlu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: